Daily FNArena News - Australia

ResMed delivered strong revenue growth in the September quarter but is expected to sustain more growth challenges as FY16 gets underway.

Weekly update on recommendation, target price, and earnings forecast changes.

Wesfarmers’ retail businesses delivered across the board sales growth in the September quarter and appear resilient, but most brokers find valuation support is only modest.

Super Retail offered a modestly upbeat outlook for FY16 at its AGM update but broker expectations diverge somewhat.

FNArena’s weekly update on short positions in the Australian share market.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Spark New Zealand is stepping up its plans to exploit key markets in mobile, broadband and communications technology.

The government’s response to the financial systems inquiry is expected to underpin Challenger’s annuity growth.

Weekly Update on ASX-listed companies buying in their own stock.

Perpetual countered a weak September quarter with the news it has a new $1bn mandate but several brokers want more evidence on the next phase of growth before becoming more positive.